You are here

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Consultorios Especializados en Investigaciones Medicas
Capital Federal, Buenos Aires, C1425EKF Argentina
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-69 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of Rheumatoid Arthritis (RA)

- Currently receiving a suboptimal response to a stable dose of methotrexate for
treatment of Rheumatoid Arthritis (RA)

- Active Rheumatoid Arthritis (RA) at time of screening and baseline

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous or current treatment with etanercept, other tumor necrosis factor-alpha
inhibitors, or other biologic agents

- Concurrent treatment with a Disease Modifying Antirheumatic Drug (DMARD), other than
methotrexate, at screening

- Receipt of any Disease Modifying Antirheumatic Drug (DMARD), other than methotrexate,
within 3 months before screening

NCT00848354
Pfizer
Completed
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis
NCT00471874
All Genders
18+
Years
Multiple Sites
Rheumatoid Arthritis
NCT00641225
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now